Blair William & CO Pacira Bio Sciences, Inc. Transaction History

Blair William & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$60.03 - $76.49 $27,013 - $34,420	-450 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$59.18 - $69.99 $1,183 - $1,399	-20 Reduced 4.26%	450 $27,000
Q4 2020 Feb 09, 2021	SELL	$50.47 - $66.26 $353 - $463	-7 Reduced 1.47%	470 $28,000
Q3 2020 Nov 06, 2020	BUY	$51.97 - $63.0 $1,403 - $1,701	27 Added 6.0%	477 $29,000
Q4 2019 Feb 13, 2020	BUY	$36.31 - $46.83 $16,339 - $21,073	450 New	450 $20,000

264

50.6M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $769M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

Stay updated on Blair William & CO with notifications on news.